Project profile — CHVI - HIV/AIDS Prevention Trials Capacity Building - Phase II

• Africa, regional (100.00%)

• Population Policies/Programmes And Reproductive Health: STD control including HIV/AIDS (13040) (100.00%)

• Gender equality (not targeted)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (not targeted)
• Youth Issues (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• ICT as a tool for development (not targeted)

The goal of this program under the Clinical Trials Capacity Building component of the Canadian HIV Vaccine Initiative (CHVI) is to strengthen the capacity of researchers and research institutions to conduct high-quality clinical trials, and to build site capacity to undertake clinical trials of HIV vaccines and other preventive technologies, in low- and middle-income countries. The second phase of the project continues to support building sustainable African capacity and leadership to conduct future HIV/AIDS prevention trials, with a special focus on innovations in HIV vaccines trials. The project also seeks to advance the collaboration and networking of African, Canadian, and international researchers and institutions in global HIV/AIDS prevention trials. The project intends to build capacity at multiple levels (individual, team, institution, network, etc.), while emphasizing the need to extend the concept of capacity beyond the traditional technical and scientific skills to include management, leadership, administration, and community and policy engagement.

N/A

Results achieved as of March 2013 include: Nine project teams in 14 African countries have started their work to strengthen the ability and leadership of African researchers and research institutions to conduct future HIV/AIDS prevention trials; five complementary research grants were awarded to young African researchers to increase research and development activities; two African-based research teams completed their projects that build stronger infrastructure and procedures for clinical trials; the number of collaborations between Canadian and African researchers increased through the convention of the Afri-Can Forum and by engaging with Health Canada and the Canadian Institutes of Health Research; in Botswana, the knowledge about the use of evidence was increased through the training of 58 parliamentarians, including five Ministers; additional funds were obtained for two research teams supported by this program; in Benin, two students completed their doctoral degrees and one physician completed a Master’s of Science degree in epidemiology through support of this program.

• Proactive disclosure
• Related activities: CHVI HIV/AIDS Prevention Trials Capacity Building - Phase II